UBS Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
131,481
+84,052
| +177% | +$1.57M | ﹤0.01% | 3654 |
|
|
2025
Q1 | $860K | Sell |
47,429
-6,432
| -12% | -$117K | ﹤0.01% | 4306 |
|
|
2024
Q4 | $1.17M | Buy |
53,861
+25,433
| +89% | +$554K | ﹤0.01% | 4107 |
|
|
2024
Q3 | $778K | Buy |
28,428
+20,019
| +238% | +$548K | ﹤0.01% | 3785 |
|
|
2024
Q2 | $218K | Sell |
8,409
-6,096
| -42% | -$158K | ﹤0.01% | 4492 |
|
|
2024
Q1 | $435K | Buy |
14,505
+14,125
| +3,717% | +$424K | ﹤0.01% | 4198 |
|
|
2023
Q4 | $3.95K | Buy |
380
+61
| +19% | +$634 | ﹤0.01% | 6710 |
|
|
2023
Q3 | $4.36K | Sell |
319
-380
| -54% | -$5.2K | ﹤0.01% | 6304 |
|
|
2023
Q2 | $8.47K | Buy |
699
+524
| +299% | +$6.35K | ﹤0.01% | 6158 |
|
|
2023
Q1 | $2.22K | Buy |
+175
| New | +$2.22K | ﹤0.01% | 7448 |
|
|
2022
Q4 | – | Sell |
-517
| Closed | -$12K | – | 9559 |
|
|
2022
Q3 | $12K | Buy |
+517
| New | +$12K | ﹤0.01% | 7053 |
|
|
2022
Q1 | – | Sell |
-451
| Closed | -$32K | – | 9246 |
|
|
2021
Q4 | $32K | Buy |
451
+449
| +22,450% | +$31.9K | ﹤0.01% | 6215 |
|
|
2021
Q3 | $0 | Sell |
2
-8
| -80% | – | ﹤0.01% | 8425 |
|
|
2021
Q2 | $2K | Sell |
10
-77
| -89% | -$15.4K | ﹤0.01% | 7824 |
|
|
2021
Q1 | $17K | Sell |
87
-178
| -67% | -$34.8K | ﹤0.01% | 6485 |
|
|
2020
Q4 | $33K | Buy |
+265
| New | +$33K | ﹤0.01% | 5548 |
|
|
2019
Q4 | – | Sell |
-562
| Closed | -$92K | – | 7036 |
|
|
2019
Q3 | $92K | Buy |
562
+481
| +594% | +$78.7K | ﹤0.01% | 4887 |
|
|
2019
Q2 | $19K | Sell |
81
-32
| -28% | -$7.51K | ﹤0.01% | 5766 |
|
|
2019
Q1 | $30K | Buy |
+113
| New | +$30K | ﹤0.01% | 5114 |
|
|
2018
Q4 | – | Sell |
-99
| Closed | -$19K | – | 7091 |
|
|
2018
Q3 | $19K | Buy |
99
+29
| +41% | +$5.57K | ﹤0.01% | 5901 |
|
|
2018
Q2 | $15K | Buy |
+70
| New | +$15K | ﹤0.01% | 5964 |
|